The development schedule calls for tenant improvements to begin in the third quarter of 2006 and occupancy in the second quarter of 2007. The goal from an environmental standpoint is to achieve a silver certification from the Leadership in Energy and Environmental Design organization run by the US Green Building Council.
The project will be in close proximity to the facilities of other life science organizations. Nearby operators include University of Washington School of Medicine, the Fred Hutchinson Cancer Research Center, Seattle Biomedical Research Institute, Seattle Cancer Care Alliance, Children's Hospital and Merck Pharmaceuticals.
BioMed already owns two properties in the Seattle area, a 135,000-sf lab and office building at 201 Elliott Ave. in Seattle and a 51,000-sf two-building development in Bothell known as Elliott Park. A BioMed executive could not be reached Thursday for comment and neither could Erlandson, who doubles as a broker for Alexander Commercial Real Estate.
BioMed president Alan Gold in a prepared statement says EDG and Erlandson have significant experience leasing and developing laboratory facilities in the Puget Sound region, including the Monte Villa Parkway property that BioMed acquired in August 2004.
In June, BioMed made what it described as a landmark acquisition, paying $523 million for a 1.1 million-sf eight-building portfolio in Cambridge, MA, and Lebanon, NH. The acquisition established BioMed as one of the larger owners of life science office and laboratory space in the Cambridge market. BioMed's real estate portfolio now stands at around 4.2 million sf in 55 buildings in 35 separate developments. <P
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
